Viewing Study NCT06587867


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-02-24 @ 5:50 AM
Study NCT ID: NCT06587867
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2024-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Seronegative Myasthenia Gravis - Efgartigimod IV
Sponsor: University Health Network, Toronto
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Efgartigimod View
None Generalized Myasthenia Gravis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None seronegative View
None generalized myasthenia gravis View